Calidi Biotherapeutics, Inc.
Cash Flow History
| Period | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| Mar 2022 | $-465.1K | $-465.1K | — | — |
| Jun 2022 | $-268.7K | $-268.7K | — | — |
| Sep 2022 | $-8.6M | $-8.6M | — | — |
| Dec 2022 | $-3.9M | $-3.9M | — | — |
| Mar 2023 | $-3.1M | $-3.1M | — | $1.4M |
| Jun 2023 | $-5.2M | $-5.2M | — | $1.1M |
| Sep 2023 | $-13.5M | $-13.5M | — | $1.1M |
| Dec 2023 | $-5.2M | $-5.2M | — | $1.2M |
| Mar 2024 | $-3.8M | $-3.8M | — | $888.0K |
| Jun 2024 | $-5.5M | $-5.5M | — | $751.0K |
| Sep 2024 | $-4.9M | $-4.9M | — | $692.0K |
| Dec 2024 | $-5.4M | $-5.4M | — | $626.0K |
| Mar 2025 | $-7.1M | $-7.1M | — | $607.0K |
| Jun 2025 | $-4.9M | $-4.9M | — | $522.0K |
| Sep 2025 | $-4.2M | $-4.2M | — | $529.0K |
| Dec 2025 | $-5.0M | $-5.0M | — | $450.0K |
| Mar 2026 | $-4.1M | $-4.1M | — | $231.0K |
| Jun 2026 | $-4.4M | $-4.4M | — | $157.0K |